BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, Xue D, Bankhead A 3rd, Neamati N. Why All the Fuss about Oxidative Phosphorylation (OXPHOS)? J Med Chem 2020;63:14276-307. [PMID: 33103432 DOI: 10.1021/acs.jmedchem.0c01013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xue D, Xu Y, Kyani A, Roy J, Dai L, Sun D, Neamati N. Discovery and Lead Optimization of Benzene-1,4-disulfonamides as Oxidative Phosphorylation Inhibitors. J Med Chem 2022;65:343-68. [PMID: 34982568 DOI: 10.1021/acs.jmedchem.1c01509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zunica ERM, Axelrod CL, Cho E, Spielmann G, Davuluri G, Alexopoulos SJ, Beretta M, Hoehn KL, Dantas WS, Stadler K, King WT, Pergola K, Irving BA, Langohr IM, Yang S, Hoppel CL, Gilmore LA, Kirwan JP. Breast cancer growth and proliferation is suppressed by the mitochondrial targeted furazano[3,4-b]pyrazine BAM15. Cancer Metab 2021;9:36. [PMID: 34627389 DOI: 10.1186/s40170-021-00274-5] [Reference Citation Analysis]
3 Huang J, Zhao L, Zhou X, Liu L, Zheng R, Deng F, Liu Y, Yu X, Li S, Cheng H. Carrier Free O 2 ‐Economizer for Photodynamic Therapy Against Hypoxic Tumor by Inhibiting Cell Respiration. Small. [DOI: 10.1002/smll.202107467] [Reference Citation Analysis]
4 Cui HR, Zhang JY, Cheng XH, Zheng JX, Zhang Q, Zheng R, You LZ, Han DR, Shang HC. Immunometabolism at the service of traditional Chinese medicine. Pharmacol Res 2022;:106081. [PMID: 35033650 DOI: 10.1016/j.phrs.2022.106081] [Reference Citation Analysis]
5 Liu J, Chen T, Yang M, Zhong Z, Ni S, Yang S, Shao F, Cai L, Bai J, Yu H. Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma. Front Cell Dev Biol 2021;9:753004. [PMID: 34901000 DOI: 10.3389/fcell.2021.753004] [Reference Citation Analysis]
6 Jin X, Li L, Peng Q, Gan C, Gao L, He S, Tan S, Pu W, Liu Y, Gong Y, Yao Y, Wang G, Liu X, Gong M, Lei P, Zhang H, Qi S, Xu H, Hu H, Dong B, Peng Y, Su D, Dai L. Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2. iScience 2022;25:104349. [PMID: 35602963 DOI: 10.1016/j.isci.2022.104349] [Reference Citation Analysis]
7 Shelton PMM, Kapoor TM. A wrench in the motor. Nat Chem Biol 2021. [PMID: 34857957 DOI: 10.1038/s41589-021-00897-1] [Reference Citation Analysis]
8 Thomas E, Thankan RS, Purushottamachar P, Huang W, Kane MA, Zhang Y, Ambulos N, Weber DJ, Njar VCO. Transcriptome profiling reveals that VNPP433-3β, the lead next-generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial-mesenchymal transition and stem cell markers. Mol Carcinog 2022. [PMID: 35512605 DOI: 10.1002/mc.23406] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xue D, Xu Y, Kyani A, Roy J, Dai L, Sun D, Neamati N. Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer. J Med Chem 2022;65:3404-19. [PMID: 35167303 DOI: 10.1021/acs.jmedchem.1c01934] [Reference Citation Analysis]
10 Sakai T, Matsuo Y, Okuda K, Hirota K, Tsuji M, Hirayama T, Nagasawa H. Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment. Sci Rep 2021;11:4852. [PMID: 33649449 DOI: 10.1038/s41598-021-83708-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kalyanaraman B. Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research. FASEB J 2022;36:e22226. [PMID: 35233843 DOI: 10.1096/fj.202101862R] [Reference Citation Analysis]
12 Cheng G, Hardy M, Topchyan P, Zander R, Volberding P, Cui W, Kalyanaraman B. Mitochondria-targeted hydroxyurea inhibits OXPHOS and induces antiproliferative and immunomodulatory effects. iScience 2021;24:102673. [PMID: 34189437 DOI: 10.1016/j.isci.2021.102673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sheng L, Fu D, Cao Y, Huo Y, Wang S, Shen R, Xu P, Cheng S, Wang L, Zhao W. Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers. Front Oncol 2022;12:790720. [DOI: 10.3389/fonc.2022.790720] [Reference Citation Analysis]
14 Unten Y, Murai M, Koshitaka T, Kitao K, Shirai O, Masuya T, Miyoshi H. Comprehensive understanding of multiple actions of anticancer drug tamoxifen in isolated mitochondria. Biochim Biophys Acta Bioenerg 2022;1863:148520. [PMID: 34896079 DOI: 10.1016/j.bbabio.2021.148520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]